ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 790

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Saffron�s bioactive molecule prevents chemical induced-liver cancer: A preclinical study

International Conference and Expo on Biopharmaceutics

Amr Amin

United Arab Emirates University, UAE

ScientificTracks Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Hepatocellular carcinoma (HCC) is the second most common cause of cancer related death worldwide. The prognosis of patients with HCC is usually poor. Hence, a novel approach against HCC is essential for a better therapeutic outcome. Saffron and its active constituents were reported to have antioxidant, anti-inflammatory, and anti-tumor properties. The aim of this study was to investigate chemo-preventive action of crocin, one of the promising active constituents of saffron, against diethylnitrosamine (DEN)- induced liver cancer in rats, and the possible mechanisms by which crocin exerts its antitumor effects. Findings reported herein demonstrated the anti-proliferative and pro-apoptotic properties of crocin when administrated in DEN-treated rats. Additionally, crocin exhibited anti-inflammatory properties that inhibited NF-kB, among other inflammatory markers. According to our network analysis, NF-kB was identified as a regulatory hub, and therefore, a candidate therapeutic drug target. Together, these findings nominate crocin as a candidate chemo-preventive and therapeutic agent against HCC.
Biography

Amr Amin has completed his PhD at University of Illinois at Chicago, and received a Post-Doctoral training in the field of molecular genetics at the University of Pennsylvania, School of Medicine. He started his academic career at UAE University where he serves now as a Full Professor of Cell Biology. Amr’s research focuses on ways to control cancer, particularly, liver cancer. He published many research articles and reviews and serves as Reviewer and as an Editorial Member of many specialized peer-reviewed journals. He is also a Member of many specialized societies and the sole recipient of many scientific awards.

Email: a.amin@uaeu.ca.ae

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top